Trial intelligence / Profile preview

Intravenous caffeine for prevention of spinal anesthesia-induced hypotension during elective cesarean section

IRCT20211011052726N5Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hypotension induced by spinal anesthesia comparing Caffeine with Placebo (2 arms). Primary endpoint: Incidence of post-spinal hypotension. Started Dec 2025; status: completed.

02

Drugs

caffeine
03

Conditions

hypotension induced by spinal anesthesia

Beyond the preview

Go deeper on IRCT20211011052726N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211011052726N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call